Tergus Pharma

Tergus Pharma is a dermatology-focused organization offering complete pharmaceutical product development services to the pharmaceutical and biotechnology industries utilizing in-vitro penetration models and other scientific tools. Tergus Pharma operates from its cGMP compliant, state of the art facilities based in Research Triangle Park (RTP), North Carolina. Tergus (Latin for “skin”) provides dermatology drug development services from concept to commercialization. Tergus Pharma services its clients with a broad range of topical drug development services, including product development strategy & design; target product profile development; formulation development; analytical method development & validation; IVRT and skin permeation studies, preclinical & clinical supplies manufacturing; program management & logistics leadership; scale-up & technology transfer oversight; regulatory CMC consulting; disease model development; clinical development strategy; and development plan creation to ensure fastest path to in vivo or clinical proof of concept studies. The company's core expertise is focused in topical dosage forms, including creams, ointments, lotions, liquids, suspensions, gels, hydrogels, pastes, pump sprays, topical aerosols, foams, microencapsulation, liposomes, suppositories and nail lacquers.